⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)

Official Title: A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (KEYNOTE-B96/ENGOT-ov65)

Study ID: NCT05116189

Study Description

Brief Summary: The primary objective is to compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab, with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by the investigator. The hypotheses are that pembrolizumab plus paclitaxel with or without bevacizumab is superior to placebo plus paclitaxel with or without bevacizumab, with respect to PFS per RECIST 1.1 as assessed by the investigator for participants with programmed cell death ligand 1 (PD-L1) positive tumors (Combined Positive Score \[CPS\] ≥1) and that pembrolizumab plus paclitaxel with or without bevacizumab is superior to placebo plus paclitaxel with or without bevacizumab, with respect to PFS per RECIST 1.1 as assessed by the investigator for all participants.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

HonorHealth ( Site 0041), Phoenix, Arizona, United States

Marin Cancer Care ( Site 0055), Greenbrae, California, United States

Pacific Cancer Care ( Site 0028), Monterey, California, United States

Eisenhower Medical Center ( Site 0067), Rancho Mirage, California, United States

Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0004), New Haven, Connecticut, United States

University of Florida College of Medicine-UF Health Cancer Center/Clinical Trials Office ( Site 0054, Gainesville, Florida, United States

Sarasota Memorial Hospital ( Site 0018), Sarasota, Florida, United States

Moffitt Cancer Center ( Site 0033), Tampa, Florida, United States

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0005), Marietta, Georgia, United States

Advocate Medical Group-Oncology ( Site 0049), Park Ridge, Illinois, United States

Parkview Research Center at Parkview Regional Medical Center ( Site 0027), Fort Wayne, Indiana, United States

St. Vincent Hospital and Health Care Center, Inc ( Site 0032), Indianapolis, Indiana, United States

Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0040), Edgewood, Kentucky, United States

WK Physicians Network / Hematology Oncology Associates ( Site 0034), Shreveport, Louisiana, United States

Mercy Medical Center - Baltimore-Medical Oncology and Hematology ( Site 0015), Baltimore, Maryland, United States

University of Massachusetts Chan Medical School-Division of Gynecologic Oncology ( Site 0003), Worcester, Massachusetts, United States

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0007), Hackensack, New Jersey, United States

Roswell Park Cancer Institute ( Site 0039), Buffalo, New York, United States

Columbia University Medical Center ( Site 0010), New York, New York, United States

Novant Health Presbyterian Medical Center ( Site 0029), Charlotte, North Carolina, United States

Duke Cancer Institute ( Site 0038), Durham, North Carolina, United States

Novant Health Forsyth Medical Center ( Site 0057), Winston-Salem, North Carolina, United States

Aultman Hospital-Oncology Clinical Trials ( Site 0009), Canton, Ohio, United States

MetroHealth Medical Center-Cancer Care Center ( Site 0047), Cleveland, Ohio, United States

Providence Portland Medical Center ( Site 0048), Portland, Oregon, United States

University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0024), Pittsburgh, Pennsylvania, United States

Sanford Cancer Center ( Site 0064), Sioux Falls, South Dakota, United States

The West Clinic, PLLC dba West Cancer Center ( Site 0058), Germantown, Tennessee, United States

Texas Oncology - Dallas (Presbyterian) ( Site 0065), Dallas, Texas, United States

Texas Oncology - The Woodlands_Lee ( Site 0043), The Woodlands, Texas, United States

Inova Schar Cancer Institute ( Site 0019), Fairfax, Virginia, United States

Westmead Hospital-Department of Gynaecological Oncology ( Site 0201), Westmead, New South Wales, Australia

Gallipoli Medical Research Foundation-GMRF CTU ( Site 0202), Brisbane, Queensland, Australia

Epworth Freemasons ( Site 0204), Melbourne, Victoria, Australia

St. John of God Subiaco Hospital ( Site 0203), Subiaco, Western Australia, Australia

Institut Jules Bordet-Medicine Oncology ( Site 0302), Bruxelles, Bruxelles-Capitale, Region De, Belgium

UZ Gent-Medical oncology ( Site 0301), Gent, Oost-Vlaanderen, Belgium

UZ Leuven ( Site 0303), Leuven, Vlaams-Brabant, Belgium

AZ Groeninge Campus Kennedylaan-Oncology ( Site 0305), Kortrijk, West-Vlaanderen, Belgium

Hospital Araújo Jorge ( Site 0401), Goiânia, Goias, Brazil

Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0404), Natal, Rio Grande Do Norte, Brazil

ANIMI - Unidade de Tratamento Oncologico ( Site 0408), Lages, Santa Catarina, Brazil

BP - A Beneficencia Portuguesa de São Paulo ( Site 0403), São Paulo, Sao Paulo, Brazil

Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0405), São Paulo, Sao Paulo, Brazil

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA-Pesquisa Clinica HC II ( Site 0402), Rio de Janeiro, , Brazil

Tom Baker Cancer Center ( Site 0511), Calgary, Alberta, Canada

BC Cancer Abbotsford ( Site 0512), Abbotsford, British Columbia, Canada

BC Cancer Victoria ( Site 0513), Victoria, British Columbia, Canada

Kingston Health Sciences Centre-Kingston General Hospital Si-Oncology and/or Hematology - Gynecolog, Kingston, Ontario, Canada

Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0508), Toronto, Ontario, Canada

CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0501), Montreal, Quebec, Canada

Jewish General Hospital ( Site 0505), Montreal, Quebec, Canada

McGill University Health Centre ( Site 0502), Montréal, Quebec, Canada

Saskatoon Cancer Center ( Site 0510), Saskatoon, Saskatchewan, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Quebec, , Canada

James Lind Centro de Investigación del Cáncer ( Site 0602), Temuco, Araucania, Chile

CIDO SpA-Oncology ( Site 0608), Temuco, Araucania, Chile

Clínica Puerto Montt ( Site 0601), Puerto Montt, Los Lagos, Chile

Oncovida ( Site 0603), Santiago, Region M. De Santiago, Chile

Instituto de Radiomedicina-hemato-oncologia ( Site 0604), Santiago, Region M. De Santiago, Chile

Clínica Vespucio-Hemato - Ocology ( Site 0607), Santiago, Region M. De Santiago, Chile

Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 0609), Santiago, Region M. De Santiago, Chile

Bradfordhill ( Site 0605), Santiago, Region M. De Santiago, Chile

Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0709), Hefei, Anhui, China

Beijing Cancer hospital ( Site 0711), Beijing, Beijing, China

Beijing Peking Union Medical College Hospital-Gynecological center of tumor ( Site 0702), Beijing, Beijing, China

Fujian Provincial Cancer Hospital ( Site 0713), Fuzhou, Fujian, China

Lanzhou university second hospital ( Site 0734), Lanzhou, Gansu, China

Zhujiang Hospital ( Site 0739), Guangzhou, Guangdong, China

Affiliated Hospital of Guangdong Medical University ( Site 0743), Zhanjiang, Guangdong, China

Guangxi Medical University Affiliated Tumor Hospital ( Site 0717), Nanning, Guangxi, China

Hainan General Hospital ( Site 0736), Haikou, Hainan, China

Henan Cancer Hospital ( Site 0718), Zhengzhou, Henan, China

Wuhan Union Hospital-Medical Oncology ( Site 0735), Wuhan, Hubei, China

Hubei Cancer Hospital-Hubei Cancer Hospital ( Site 0708), Wuhan, Hubei, China

Xiangya Hospital Central South University-Gynecology ( Site 0705), Changsha, Hunan, China

Hunan Cancer Hospital ( Site 0704), Changsha, Hunan, China

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (, Nanjing, Jiangsu, China

Zhongda Hospital Southeast University ( Site 0723), Nanjing, Jiangsu, China

Jiangxi Maternal and Child Health Hospital-Oncology Department ( Site 0716), Nanchang, Jiangxi, China

The First Hospital of Jilin University ( Site 0710), Changchun, Jilin, China

Shandong Cancer Hospital-Oncology Department ( Site 0733), Jinan, Shandong, China

LinYi Cancer Hospital ( Site 0731), Linyi, Shandong, China

Obstetrics & Gynecology Hospital of Fudan University ( Site 0715), Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center-Gynecologic Oncology Department ( Site 0701), Shanghai, Shanghai, China

Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0744), Shanghai, Shanghai, China

West China Second University Hospital Sichuan University ( Site 0740), Chengdu, Sichuan, China

Tianjin Central Hosptial of Gynecology Obstetrics ( Site 0737), Tianjin, Tianjin, China

Tianjin Medical University Cancer Institute and Hospital ( Site 0720), Tianjin, Tianjin, China

Yunnan Province Cancer Hospital-Gynecology Department ( Site 0714), Kunming, Yunnan, China

The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0741), Hangzhou, Zhejiang, China

The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0706), Wenzhou, Zhejiang, China

Fundación Colombiana de Cancerología Clínica Vida ( Site 0808), Medellin, Antioquia, Colombia

Clinica de la Costa LTDA-Clinical Research Oncology & Hematology -Pediatric ( Site 0809), Barranquilla, Atlantico, Colombia

Clínica Universitaria Colombia ( Site 0806), Bogotá, Distrito Capital De Bogota, Colombia

Oncologos del Occidente ( Site 0807), Pereira, Risaralda, Colombia

Hemato Oncologos SA ( Site 0801), Cali, Valle Del Cauca, Colombia

Aalborg Universitetshospital, Syd ( Site 0901), Aalborg, Nordjylland, Denmark

Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1001), Turku, Varsinais-Suomi, Finland

Centre Hospitalier Régional Universitaire de Brest - Hôpital-Institut de cancérologie et hématologi, Brest, Bretagne, France

Centre François Baclesse-Recherche clinique ( Site 2904), Caen, Calvados, France

Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren-oncologie ( Site 2907), Limoges, Haute-Vienne, France

Institut Curie - site Saint-Cloud ( Site 2909), Saint-Cloud, Hauts-de-Seine, France

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer-Medical Oncology ( Site 2901), Rennes, Ille-et-Vilaine, France

Centre de Cancérologie du Grand Montpellier ( Site 2908), Montpellier, Languedoc-Roussillon, France

Hôpital privé du Confluent SAS-Service d'oncologie médicale ( Site 2905), Nantes, Loire-Atlantique, France

Universitaetsklinikum Erlangen-Klinik für Gynäkologie und Geburtshilfe ( Site 1205), Erlangen, Bayern, Germany

Universitätsklinikum Bonn-Gynaecological oncology ( Site 1203), Bonn, Nordrhein-Westfalen, Germany

Universitaetsklinikum Duesseldorf-Klinik für Frauenheilkunde & Geburtshilfe ( Site 1204), Düsseldorf, Nordrhein-Westfalen, Germany

Zentrum fuer ambulante gynaekologische Onkologie (ZAGO) ( Site 1207), Krefeld, Nordrhein-Westfalen, Germany

CaritasKlinikum Saarbrücken St. Theresia ( Site 1211), Saarbrücken, Saarland, Germany

Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden, Sachsen, Germany

Universitätsklinikum Leipzig-Department of Gynecology and Obstetrics ( Site 1213), Leipzig, Sachsen, Germany

Charité Campus Virchow-Klinikum ( Site 1201), Berlin, , Germany

Asklepios Kliniken Hamburg-Asklepios Klinik Barmbek ( Site 1214), Hamburg, , Germany

St. James's Hospital-Cancer clinical trials office ( Site 2821), Dublin, , Ireland

Emek Medical Center-Gyn-Onc ( Site 1406), Afula, , Israel

Soroka Medical Center ( Site 1404), Be'er Sheva, , Israel

Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), Haifa, , Israel

Shaare Zedek Medical Center ( Site 1405), Jerusalem, , Israel

Rabin Medical Center ( Site 1401), Petah-Tikva, , Israel

Sheba Medical Center ( Site 1407), Ramat Gan, , Israel

Sourasky Medical Center ( Site 1403), Tel Aviv, , Israel

IRCCS - AOU di Bologna-SSD Oncologia medica Addarii ( Site 1501), Bologna, Emilia-Romagna, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1503), Milan, Lombardia, Italy

Ospedale San Gerardo-ASST Monza-Oncologia ( Site 1508), Monza, Lombardia, Italy

ASST Grande Ospedale Metropolitano Niguarda ( Site 1505), Milan, Milano, Italy

Ospedale Mauriziano-Ginecologia e Ostetricia ( Site 1507), Torino, Piemonte, Italy

Azienda Ospedaliera Spedali Civili di Brescia ( Site 1504), Brescia, , Italy

Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 1502), Milano, , Italy

Aichi Cancer Center Hospital ( Site 1610), Nagoya, Aichi, Japan

National Cancer Center Hospital East ( Site 1609), Kashiwa, Chiba, Japan

National Hospital Organization Shikoku Cancer Center ( Site 1603), Matsuyama, Ehime, Japan

Ehime University Hospital ( Site 1606), Toon, Ehime, Japan

Kurume University Hospital ( Site 1607), Kurume, Fukuoka, Japan

Hokkaido University Hospital ( Site 1604), Sapporo, Hokkaido, Japan

Iwate Medical University Hospital ( Site 1613), Shiwa-gun Yahaba-cho, Iwate, Japan

Nippon Medical School Musashi Kosugi Hospital ( Site 1614), Kawasaki, Kanagawa, Japan

Saitama Medical University International Medical Center ( Site 1601), Hidaka-shi, Saitama, Japan

Shizuoka Cancer Center ( Site 1611), Nagaizumi, Shizuoka, Japan

National Cancer Center Hospital ( Site 1612), Chuo-ku, Tokyo, Japan

Japanese Foundation for Cancer Research ( Site 1605), Koto, Tokyo, Japan

Osaka International Cancer Institute ( Site 1602), Osaka, , Japan

Seoul National University Hospital ( Site 2302), Seoul, , Korea, Republic of

Severance Hospital, Yonsei University Health System-Gynecologic cancer center ( Site 2303), Seoul, , Korea, Republic of

Asan Medical Center-Division of Gynecologic Oncology, Dept. of Obstetrics & Gynecology ( Site 2304), Seoul, , Korea, Republic of

Gangnam Severance Hospital ( Site 2301), Seoul, , Korea, Republic of

Investigación Oncofarmacéutica-Investigación clínica ( Site 1706), La Paz, Baja California Sur, Mexico

COI Centro Oncologico Internacional S.A.P.I. de C.V.-Investigation Unit COI ( Site 1703), Mexico City, Distrito Federal, Mexico

INSTITUTO NACIONAL DE CANCEROLOGIA ( Site 1701), Mexico City, Distrito Federal, Mexico

iCan Oncology Center Centro Medico AVE ( Site 1704), Monterrey, Nuevo Leon, Mexico

Centro de Investigacion Clinica de Oaxaca ( Site 1705), Oaxaca, , Mexico

Radboudumc ( Site 1802), Nijmegen, Gelderland, Netherlands

Leids Universitair Medisch Centrum-Medical Oncology ( Site 1801), Leiden, Zuid-Holland, Netherlands

Erasmus Medisch Centrum-Medical Oncology ( Site 1803), Rotterdam, Zuid-Holland, Netherlands

Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 1804), Utrecht, , Netherlands

Auckland City Hospital ( Site 1901), Auckland, , New Zealand

Universitetssykehuset Nord-Norge HF-Kreftavdelingen ( Site 2001), Tromsø, Troms, Norway

Szpital Kliniczny im. Księżnej Anny Mazowieckiej ( Site 2103), Warsaw, Mazowieckie, Poland

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Gynecological Oncology Department ( Sit, Warszawa, Mazowieckie, Poland

Bialostockie Centrum Onkologii-Oddzial Onkologii Ginekologicznej ( Site 2106), Bialystok, Podlaskie, Poland

Uniwersytecki Szpital Kliniczny w Bialymstoku-Uniwersyteckie Centrum Onkologii ( Site 2104), Bialystok, Podlaskie, Poland

Uniwersyteckie Centrum Kliniczne-Klinika Ginekologii, Ginekologii Onkologicznej i Endokrynologii Gi, Gdańsk, Pomorskie, Poland

Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 21, Gliwice, Slaskie, Poland

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 2107), Kielce, Swietokrzyskie, Poland

Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Me-Oddzial Ginekologii Onkologicznej ( Sit, Poznan, Wielkopolskie, Poland

Chelyabinsk Regional Clinical Oncology Dispensary-Chelyabinsk Regional Clinical Oncology Dispensary, Chelyabinsk, Chelyabinskaya Oblast, Russian Federation

Ogarev Mordovia State University ( Site 2209), Saransk, Mordoviya, Respublika, Russian Federation

Moscow City Oncology Hospital #62 ( Site 2214), Krasnogorsk D-t, Moskovskaya Oblast, Russian Federation

Fed State Budgetary Inst "N.N. Blokhin Med Center of Oncology" MHRF-Chemotherapy #2 ( Site 2211), Moscow, Moskva, Russian Federation

SVERDLOVSK REGIONAL ONCOLOGY DISPENSARY-Oncogynecology Department ( Site 2216), Ekaterinburg, Sverdlovskaya Oblast, Russian Federation

cukurova universty ( Site 2706), Sarçam, Adana, Turkey

Istanbul Universitesi Cerrahpasa ( Site 2709), Fatih, Istanbul, Turkey

Ege University Medicine of Faculty ( Site 2702), Bornova, Izmir, Turkey

Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 2704), Adana, , Turkey

Ankara University Hospital Cebeci ( Site 2701), Ankara, , Turkey

Baskent Universitesi Ankara Hastanesi ( Site 2707), Ankara, , Turkey

Bezmialem Vakf Üniversitesi-Oncology ( Site 2705), Istanbul, , Turkey

T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma, Istanbul, , Turkey

Brighton and Sussex University Hospitals NHS Trust ( Site 2803), East Sussex, Brighton And Hove, United Kingdom

Addenbrooke's Hospital ( Site 2808), Cambridge, Cambridgeshire, United Kingdom

The Royal Cornwall Hospital ( Site 2804), Truro, Cornwall, United Kingdom

Westmorland General Hospital ( Site 2815), Kendal, Cumbria, United Kingdom

Ninewells Hospital and Medical School ( Site 2826), Dundee, Dundee City, United Kingdom

Leicester Royal Infirmary-HOPE Clinical Trials Unit ( Site 2812), Leicester, England, United Kingdom

Hammersmith Hospital-Medical Oncology ( Site 2818), London, London, City Of, United Kingdom

Velindre Cancer Centre ( Site 2805), Cardiff, , United Kingdom

Contact Details

Name: Medical Director

Affiliation: Merck Sharp & Dohme LLC

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: